ADVERSE REACTIONS AND SEROLOGIC RESPONSE TO A BOOSTER DOSE OF ACELLULAR PERTUSSIS-VACCINE IN CHILDREN IMMUNIZED WITH ACELLULAR OR WHOLE-CELL VACCINE AS INFANTS

被引：0
|
作者：
BLENNOW, M
GRANSTROM, M
机构：
[1] KAROLINSKA INST,SACHS CHILDRENS HOSP,DEPT CLIN MICROBIOL,S-10401 STOCKHOLM 60,SWEDEN
[2] KAROLINSKA HOSP,S-10401 STOCKHOLM 60,SWEDEN
[3] KAROLINSKA INST,SACHS CHILDRENS HOSP,DEPT PEDIAT,S-10401 STOCKHOLM 60,SWEDEN
来源：
PEDIATRICS | 1989年 / 84卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：62 / 67
页数：6
相关论文
共 50 条
  • [21] ACELLULAR PERTUSSIS-VACCINE - IMMUNOGENICITY AND SAFETY OF AN ACELLULAR PERTUSSIS VS A WHOLE CELL PERTUSSIS-VACCINE COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS AS A BOOSTER IN 18-MONTH TO 24-MONTH OLD CHILDREN
    PICHICHERO, ME
    BADGETT, JT
    RODGERS, GC
    MCLINN, S
    TREVINOSCATTERDAY, B
    NELSON, JD
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (04) : 352 - 363
  • [22] Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy
    Alghounaim, Mohammad
    Alsaffar, Zainab
    Alfraij, Abdulla
    Bin-Hasan, Saadoun
    Hussain, Entesar
    MEDICAL PRINCIPLES AND PRACTICE, 2022, 31 (04) : 313 - 321
  • [23] Priming with Whole-Cell versus Acellular Pertussis Vaccine
    Liko, Juventila
    Robison, Steve G.
    Cieslak, Paul R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (06): : 581 - 582
  • [24] PHASE-II TRIAL OF WHOLE-CELL PERTUSSIS-VACCINE VS AN ACELLULAR VACCINE CONTAINING AGGLUTINOGENS
    MILLER, E
    ASHWORTH, LAE
    ROBINSON, A
    WAIGHT, PA
    IRONS, LI
    LANCET, 1991, 337 (8733): : 70 - 73
  • [25] COMPARISON OF ACELLULAR PERTUSSIS-VACCINE WITH WHOLE CELL VACCINE AS A BOOSTER IN CHILDREN 15 TO 18 MONTHS AND 4 TO 6 YEARS OF AGE
    BERNSTEIN, DI
    SMITH, VE
    SCHIFF, GM
    RATHFON, HM
    BOSCIA, JA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (02) : 131 - 135
  • [26] The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine - A postmarketing assessment
    Rosenthal, S
    Chen, R
    Hadler, S
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1996, 150 (05): : 457 - 460
  • [27] RESPONSE TO BOOSTER DOSE OF ACELLULAR PERTUSSIS-VACCINE (DT-AP) AT 4 YEARS FOLLOWING DT-AP OR WHOLE-CELL PERTUSSIS-VACCINE (WC-DTP) AT 15-20 MONTHS
    MARCINAK, JF
    HAYANI, KC
    FRANK, AL
    PEDIATRIC RESEARCH, 1995, 37 (04) : A182 - A182
  • [28] Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children
    Lacombe, K
    Yam, A
    Simondon, K
    Pinchinat, S
    Simondon, F
    VACCINE, 2004, 23 (05) : 623 - 628
  • [29] COMPARISON OF A 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE WITH A WHOLE-CELL PERTUSSIS-VACCINE IN 15-MONTH-OLD THROUGH 20-MONTH-OLD INFANTS
    BERNSTEIN, HH
    ROTHSTEIN, EP
    REISINGER, KS
    BLATTER, MM
    ARBETER, AM
    FONTANA, ME
    JACOBS, JM
    LONG, SS
    RATHFON, H
    CRAYNE, O
    KRAUSE, DS
    SCHILLER, RP
    GIRONE, JAC
    HIPP, TJ
    SOUDER, RL
    KENNEDY, TI
    FACCENDA, DR
    PEDIATRICS, 1994, 93 (04) : 656 - 659
  • [30] ACELLULAR PERTUSSIS-VACCINE (DTPA) VS WHOLE-CELL PERTUSSIS-VACCINE (DTPW) VS NATURAL INFECTION - COMPARISON OF SPECIFIC CELL-MEDIATED IMMUNE-RESPONSE
    KNUF, M
    HABERMEHL, P
    SCHMIDTKE, P
    MEYER, CU
    SCHMITT, HJ
    CLEMENS, R
    SLAOUI, M
    ZEPP, F
    PEDIATRIC RESEARCH, 1995, 38 (03) : 439 - 439
12345